Orchestra Biomed Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Orchestra BioMed Holdings, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on June 24, 2025, with voting matters including the election of directors and ratification of the company's independent auditor.
NASDAQ
Orchestra BioMed Holdings will hold its 2025 Annual Meeting of Stockholders virtually on June 24, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Orchestra BioMed Holdings, Inc. will hold its annual meeting on June 20, 2024, and is soliciting votes on the election of directors and ratification of its accounting firm.
NASDAQ
Orchestra BioMed Holdings will hold its 2024 Annual Meeting of Stockholders virtually on June 20, 2024, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.